Novartis
The Executive Director of Molecular and Cellular Sciences leads an international scientific team developing innovative biomarker strategies for Novartis's clinical portfolio. This role drives the implementation of diverse molecular approaches, supports the transition of precision medicine techniques to external providers, and defines novel biological endpoints for drug development.
Headquarters
Basel, Basel-Stadt, Switzerland
Company Size
10001+ employees
Founded
1996
Novartis is an innovative medicines company that pursues scientific breakthroughs to improve and extend people's lives. The company develops and delivers medicines across therapeutic areas including cardiovascular, immunology, neuroscience, and oncology, with its treatments reaching 296 million patients worldwide. With more than 250 years of heritage and 30 years as Novartis, the company works to turn innovations into medicines that redefine the future for patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novartis.
68% above the average for this role
Scientist - Molecular and Cellular Biology
Celerion
Sr Director, Global Translational Sciences Lead, Molecular Imaging
City of Duncan, Oklahoma
Director, Molecular Pathology, Translational Sciences, Translational Research.
Revolution Medicines
Vice President, Structural and Molecular Sciences
Revolution Medicines
Project Officer (Cell and Molecular Biology)
Nanyang Technological University
Adjunct Faculty of Molecular and Cellular Biology
Assumption University